[Federal Register Volume 76, Number 200 (Monday, October 17, 2011)]
[Notices]
[Pages 64088-64089]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-26795]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket Number NIOSH-248]
World Trade Center Health Program Scientific/Technical Advisory
Committee (WTCHP STAC or Advisory Committee), National Institute for
Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Committee Public Meeting Times and Dates: (All times are Eastern
Standard Time)
8:15 a.m.-5 p.m., November 9, 2011,
8 a.m.-12 p.m., November 10, 2011.
Public Comment Times and Dates: (All times are Eastern Standard
Time)
3:15 p.m.-4:15 p.m., November 9, 2011,
8:15 a.m.-9:15 a.m., November 10, 2011.
[[Page 64089]]
Please note that the public comment period ends at the times
indicated or following the last call for comments, whichever is
earlier. Members of the public who want to comment must sign up at the
meeting site, beginning at 8 a.m., each day, before the public comment
time. Each commenter will be provided up to five minutes for comment. A
limited number of time slots are available and will be assigned on a
first come-first served basis. Written comments will also be accepted
from those unable to attend the public sessions.
Place: Jacob K. Javits Federal Building, 26 Federal Plaza, New
York, New York, 10278.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 300 people. No additional
seating will be allowed in the meeting space. In addition, there will
be an audio conference setup for those who cannot attend in person. The
conference line will accommodate up to 300 callers; therefore it is
suggested that those interested in calling in to listen to the
committee meeting share a line when possible.
Security Considerations: Due to mandatory security clearance
procedures at the Jacob K. Javits Federal Building, in-person attendees
must present valid government-issued picture identification to security
personnel upon entering the building and go through an airport-type
security check. Non-U.S. citizens are encouraged to participate in the
audio conferencing due to the extra clearance involved with in-person
attendance. To attend in person, a non-U.S. citizen will have to call
or send an e-mail before October 25, 2011, to the contact person in
this Notice, and provide passport information. If clearance is
received, you will be notified; otherwise, you will not be able to
attend the meeting in person.
Background: The Advisory Committee was established by Public Law
111-347 (The James Zadroga 9/11 Health and Compensation Act of 2010,
Title XXXIII of the Public Health Service Act), enacted on January 2,
2011 and codified at 42 U.S.C. 300mm-300mm-61.
Purpose: The purpose of the Advisory Committee is to review
scientific and medical evidence and to make recommendations to the
World Trade Center (WTC) Program Administrator regarding additional WTC
Health Program eligibility criteria and potential additions to the list
of covered WTC-related health conditions.
Title XXXIII of the Public Health Service Act established within
the Department of Health and Human Services (HHS), the World Trade
Center (WTC) Health Program, to be administered by the WTC Program
Administrator. The WTC Health Program provides: (1) Medical monitoring
and treatment benefits to eligible emergency responders and recovery
and cleanup workers (including those who are Federal employees) who
responded to the September 11, 2011, terrorist attacks, and (2) initial
health evaluation, monitoring, and treatment benefits to residents and
other building occupants and area workers in New York City, who were
directly impacted and adversely affected by such attacks
(``survivors'').
Certain specific activities of the WTC Program Administrator are
reserved to the Secretary, HHS, to delegate at her discretion; other
WTC Program Administrator duties not explicitly reserved to the
Secretary, HHS, are assigned to the Director, NIOSH. The administration
of the Advisory Committee established under Section 300mm-1(a) is left
to the Director of NIOSH in his role as WTC Program Administrator. CDC
and NIOSH provide funding, staffing, and administrative support
services for the Advisory Committee. The charter was issued on May 12,
2011, and will expire on May 12, 2013.
Matters to be Discussed: The agenda for the Advisory Committee
meeting includes: WTC Health Program Overview; Panel Presentations from
WTC Responders and Survivors; Presentations from WTC Health Program
Medical Monitoring and Treatment Programs and Health Registry; and
discussion regarding ways and means of accomplishing the committee's
work.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may be
submitted. The comments should be limited to two pages and submitted to
the contact person below by October 28, 2011. Efforts will be made to
provide the two-page written comments received by the deadline below at
the meeting. Comments in excess of two pages will be made publicly
available at the NIOSH docket (http://www.cdc.gov/niosh/docket/archive/docket248.html). Submissions to the docket should reference docket
248, and be sent to the NIOSH Docket Office at:
Mail: NIOSH Docket Office, Robert A. Taft Laboratories,
MS-C-34, 4676 Columbia Parkway, Cincinnati, Ohio 45226.
Facsimile: (513) 533-8285.
E-mail: [email protected].
Telephone: (513) 533-8611.
Policy on Redaction of Committee Meeting Transcripts (Public
Comment): Transcripts will be prepared and posted to NIOSH Docket
248 within 30 days after the meeting. If a person making a
comment gives his or her name, no attempt will be made to redact that
name. NIOSH will take reasonable steps to ensure that individuals
making public comments are aware of the fact that their comments
(including their name, if provided) will appear in a transcript of the
meeting posted on a public Web site. Such reasonable steps include: (a)
A statement read at the start of the meeting stating that transcripts
will be posted and names of speakers will not be redacted; and (b) A
printed copy of the statement mentioned in (a) above will be displayed
on the table where individuals sign up to make public comments. If
individuals in making a statement reveal personal information (e.g.,
medical information) about themselves, that information will not
usually be redacted. The CDC Freedom of Information Act coordinator
will, however, review such revelations in accordance with the Freedom
of Information Act and if deemed appropriate, will redact such
information. Disclosures of information concerning third party medical
information will be redacted.
Contact Person for More Information: Paul J. Middendorf, PhD,
Designated Federal Official, NIOSH, CDC, 4676 Columbia Parkway Mail
Stop R-45, Cincinnati, Ohio 45226, telephone 1 (888) 982-4748; e-mail:
[email protected].
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention, and the Agency
for Toxic Substances and Disease Registry.
Dated: October 11, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2011-26795 Filed 10-14-11; 8:45 am]
BILLING CODE 4163-18-P